Company news
Trivarx Limited (ASX:TRI) news
Trivarx Limited news releases on 6ix. Latest, May 10, 2017: MEB Signs Strategic Joint Development Agreement with Mayo Cl
Press releases — page 4
MEB Signs Strategic Joint Development Agreement with Mayo Cl
May 10, 2017
Quarterly ASX Update and Cashflow
April 27, 2017
MEB enters fully funded Paediatric mental illness diagnostic
April 10, 2017
Conversion of Options to Partly Paid shares
April 5, 2017
MEB appoints US med-tech veteran as CEO & Managing Director
February 16, 2017
Early Redemption of Convertible Note
January 30, 2017
Partnership with leading US University on PTSD
January 24, 2017
Excellent performance in the pilot phase of US Validation
December 20, 2016
Medibio enters into binding agreement with Medtronic
November 24, 2016
Capital raising of $13.5million to accelerate growth
November 17, 2016
ANZ: Opes Prime Disclosure
November 7, 2016
Outstanding 86% accuracy in 889 person Ottawa Uni study
November 1, 2016
Quarterly Activities Report
October 31, 2016
Receipt of $3,074,224 R & D Tax Incentive Refund
October 14, 2016
Partners with HBF and Vital Conversations on mental health
October 10, 2016
Funding Update
October 9, 2016
Medibio and Monash Groundbreaking partnership on innovation
September 14, 2016
Commercial Trial and Validation Update
August 17, 2016
Breakthrough validation of depression test with Ottawa Univ
August 8, 2016
MEB Advanced Analytics Cloud Solution breaks new ground in S
June 24, 2016
Medibios first commercial pilot study a success
May 30, 2016
Appendix 4C - quarterly & activities report
May 1, 2016
Medibio Acquires Key IP
April 19, 2016
Successful Pre-Submission Meeting with the US FDA
March 31, 2016
Medibio appoints US based CRO for its validation trials
March 30, 2016
4 leading US Institutions provide Medibio 10,000 data sets
March 11, 2016
Swinburne Software Labs trial success with Apple Watch & FIT
March 8, 2016
Partnership to evaluate wearable applications for Mental Hea
February 11, 2016
MEB signs MOU with $100 billion NYSE listed medical company
February 10, 2016
BPO: BioProspect and Solagran agreement to commercialise
February 25, 2010